Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Cell And Gene Therapy market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Cell And Gene Therapy market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Cell And Gene Therapy market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Cell And Gene Therapy products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Cell And Gene Therapy products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Cell And Gene Therapy market.
To learn more about this report
Increasing research and development spending on Cell And Gene Therapy development has been the leading industry trend of Cell And Gene Therapy market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Rare Diseases, Oncology, Hematology, Cardiovascular, Ophthalmology, Neurology, Other Therapeutic Classes |
| By Application Outlook | Pharmaceutical and Pharmaceuticals & Healthcare Companies, Research and Academic Institutions, Contract Research Organizations (CROs), Hospital, Others |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Amgen Inc., bluebird bio, Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc., Human Stem Cells Institute, Kite Pharma, Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., Organogenesis Holdings Inc., Pfizer, Inc., RENOVA THERAPEUTICS, Shanghai Sunway Biotech Co., Ltd., , Sibiono GeneTech Co. Ltd., , Spark Therapeutics, Inc., Vericel Corporation, ViroMed Co., Ltd. |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Cell And Gene Therapy Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Cell And Gene Therapy Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Cell And Gene Therapy Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Cell And Gene Therapy Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Rare Diseases
4.2.2 Oncology
4.2.3 Hematology
4.2.4 Cardiovascular
4.2.5 Ophthalmology
4.2.6 Neurology
4.2.7 Other Therapeutic Classes
4.4 Type Comparison Matrix
4.5 Global Cell And Gene Therapy Market Attractiveness, By Type
5 Global Cell And Gene Therapy Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Cell And Gene Therapy Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Pharmaceutical and Pharmaceuticals & Healthcare Companies
5.3.2 Research and Academic Institutions
5.3.3 Contract Research Organizations (CROs)
5.3.4 Hospital
5.3.5 Others
5.4 Application Comparison Matrix
5.5 Global Cell And Gene Therapy Market Attractiveness, by Application
6 Global Cell And Gene Therapy Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Cell And Gene Therapy Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Cell And Gene Therapy Market Attractiveness, by Region
8 North America Cell And Gene Therapy Market Analysis and Forecast
8.1 Key Findings
8.2 North America Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Rare Diseases
8.2.2 Oncology
8.2.3 Hematology
8.2.4 Cardiovascular
8.2.5 Ophthalmology
8.2.6 Neurology
8.2.7 Other Therapeutic Classes
8.3 North America Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Pharmaceutical and Pharmaceuticals & Healthcare Companies
8.3.2 Research and Academic Institutions
8.3.3 Contract Research Organizations (CROs)
8.3.4 Hospital
8.3.5 Others
8.4 North America Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Cell And Gene Therapy Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Cell And Gene Therapy Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Rare Diseases
9.2.2 Oncology
9.2.3 Hematology
9.2.4 Cardiovascular
9.2.5 Ophthalmology
9.2.6 Neurology
9.2.7 Other Therapeutic Classes
9.3 Europe Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Pharmaceutical and Pharmaceuticals & Healthcare Companies
9.3.2 Research and Academic Institutions
9.3.3 Contract Research Organizations (CROs)
9.3.4 Hospital
9.3.5 Others
9.4 Europe Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Cell And Gene Therapy Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Cell And Gene Therapy Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Rare Diseases
10.2.2 Oncology
10.2.3 Hematology
10.2.4 Cardiovascular
10.2.5 Ophthalmology
10.2.6 Neurology
10.2.7 Other Therapeutic Classes
10.3 Asia Pacific Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Pharmaceutical and Pharmaceuticals & Healthcare Companies
10.3.2 Research and Academic Institutions
10.3.3 Contract Research Organizations (CROs)
10.3.4 Hospital
10.3.5 Others
10.4 Asia Pacific Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Cell And Gene Therapy Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Cell And Gene Therapy Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Rare Diseases
11.2.2 Oncology
11.2.3 Hematology
11.2.4 Cardiovascular
11.2.5 Ophthalmology
11.2.6 Neurology
11.2.7 Other Therapeutic Classes
11.3 Latin America Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Pharmaceutical and Pharmaceuticals & Healthcare Companies
11.3.2 Research and Academic Institutions
11.3.3 Contract Research Organizations (CROs)
11.3.4 Hospital
11.3.5 Others
11.4 Latin America Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Cell And Gene Therapy Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Cell And Gene Therapy Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Rare Diseases
12.2.2 Oncology
12.2.3 Hematology
12.2.4 Cardiovascular
12.2.5 Ophthalmology
12.2.6 Neurology
12.2.7 Other Therapeutic Classes
12.3 Middle East & Africa (MEA) Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Pharmaceutical and Pharmaceuticals & Healthcare Companies
12.3.2 Research and Academic Institutions
12.3.3 Contract Research Organizations (CROs)
12.3.4 Hospital
12.3.5 Others
12.4 Middle East & Africa (MEA) Cell And Gene Therapy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Cell And Gene Therapy Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Amgen Inc.
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 bluebird bio
13.3.3 Inc.
13.3.4 Dendreon Pharmaceuticals LLC.
13.3.5 Fibrocell Science
13.3.6 Inc.
13.3.7 Human Stem Cells Institute
13.3.8 Kite Pharma
13.3.9 Inc.
13.3.10 Kolon TissueGene
13.3.11 Inc.
13.3.12 Novartis AG
13.3.13 Orchard Therapeutics plc.
13.3.14 Organogenesis Holdings Inc.
13.3.15 Pfizer
13.3.16 Inc.
13.3.17 RENOVA THERAPEUTICS
13.3.18 Shanghai Sunway Biotech Co.
13.3.19 Ltd.
13.3.20
13.3.21 Sibiono GeneTech Co. Ltd.
13.3.22
13.3.23 Spark Therapeutics
13.3.24 Inc.
13.3.25 Vericel Corporation
13.3.26 ViroMed Co.
13.3.27 Ltd.
14 Key Takeaways
Choose License Type